Tango Therapeutics

Tango Therapeutics

Tango Therapeutics

Tango Therapeutics is a biotechnology company developing novel medicines
Type
B2c
Founded
2017
Raised
$165M
Follow us
Alexa global traffic share
Latest funding Show all
Team Size
10+
Employees
Pulse 2.0

Targeted Cancer Therapy Biotech Company Tango Therapeutics Raises $50 Million 

Xconomy

Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor

$50,000,000 Venture capital
FinSMEs

Tango Therapeutics Raises $50M in Equity Financing

$60,000,000 Venture capital (Series B)
Pulse 2.0

Targeted Cancer Therapies Company Tango Closes $60 Million

MedCity News

Gilead Sciences, Tango Therapeutics join forces on immuno-oncology

$55,000,000 Venture capital (Series A)
businesswire

Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment